The evolutionary conservation of the molecular mechanisms regulating metazoan development and the ease of genetic manipulation has made Drosophila an attractive model to identify potential new target genes involved in human disease. However, the field of Drosophila research is currently hindered by the lack of high quality antibody reagents to a broad spectrum of targets.
BD Biosciences Pharmingen has initiated a program to develop high-quality antibodies to further Drosophila research.
Beginning with an inventory of over 1,000 antibodies to intracellular signaling proteins, we screened each antibody for cross-reactivity to its corresponding Drosophila protein.
The results were presented in a poster at the Drosphila Research Conference:
A Proteomics Approach to Identifying Specific Cross-Reactive Anti-Human Antibodies to Drosophila Proteins 
Use the Product List button above to jump to a complete list of Drosophila specificities, or the Sample Data button to view scanning confocal microscopy and western blot images of a few select antibodies.
Watch for these releases coming soon
Phospho-Specific Antibodies to:
Cdc2 (pY15)
ERK1/2 (pT202/pY204)
p38 MAPK (pT180/pY182)
Plus, high-quality antibodies to:
Chaoptin
Cyclin B
Futsch
Syntaxin
|
